2010
Pharmacokinetics analysis of sustained release hGH biodegradable implantable tablets using a mouse model of human ovarian cancer
Santoveña A, Fariña JB, Llabrés M, Zhu Y, Dannies P. Pharmacokinetics analysis of sustained release hGH biodegradable implantable tablets using a mouse model of human ovarian cancer. International Journal Of Pharmaceutics 2010, 388: 175-180. PMID: 20060456, DOI: 10.1016/j.ijpharm.2009.12.054.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsCell ProliferationDelayed-Action PreparationsDisease Models, AnimalDrug CarriersDrug ImplantsDrug StabilityFemaleHuman Growth HormoneHumansLactic AcidLikelihood FunctionsMiceMice, SCIDOvarian NeoplasmsPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerSurvival RateTabletsTime FactorsConceptsSerum levelsSurvival timeMouse modelOvarian cancer mouse modelHormone serum levelsImmunodeficient female micePopulation pharmacokinetic modelHuman ovarian cancer cellsHuman ovarian cancerCancer mouse modelEffect of hGHOvarian cancer cellsFemale miceOvarian cancerHormone releaseOrbital vesselsTumoral cell proliferationPeritoneal cavityPharmacokinetic analysisHigh doseHormone loadSustained release devicesPharmacokinetic modelCancer cellsPharmacokinetic study
1983
3COMPARISON OF THEEFFECTS OF HISTAMINE H2-RECEPTOR ANTAGONISTS ON PROLACTIN SECRETION IN THE RAT.
NETTI C, GUIDOBONO F, OLGIATI V, SIBILIA V, PECILE A, Dannies P. 3COMPARISON OF THEEFFECTS OF HISTAMINE H2-RECEPTOR ANTAGONISTS ON PROLACTIN SECRETION IN THE RAT. Endocrinology 1983, 113: 412-414. PMID: 6305638, DOI: 10.1210/endo-113-1-412.Peer-Reviewed Original ResearchConceptsPRL releaseHistamine H2-receptor antagonistsSignificant PRL releaseH2-receptor antagonistsCentral neural controlPRL-releasing activityHistamine H2 receptorsPRL secretionBlocking actionProlactin secretionH2 receptorsSingle bolusBlood samplesHigh doseBlocking potencyPrompt increaseBrain ventriclesNeural controlDrugsCimetidineRanitidineRatsStimulating effectPRLSecretion